Bacterial biofilms: a diagnostic and therapeutic challenge
Bacterial biofilms: a diagnostic and therapeutic challenge
Bacteria have traditionally been regarded as individual organisms growing in homogeneous planktonic populations. However, bacteria in natural environments usually form communities of surface-adherent organisms embedded in an extracellular matrix, called biofilms. Current antimicrobial strategies often fail to control bacteria in the biofilm mode of growth. Treatment failure is particularly frequent in association with intracorporeal or transcutaneous medical devices and compromised host immunity. The rising prevalence of these risk factors over the last decades has paralleled the increase in biofilm infections. This review discusses the shortcomings of current therapies against biofilms both in theory and with clinical examples. Biofilm characteristics are described with a focus on new diagnostic and therapeutic targets.
667-683
Fux, Christoph A.
14e6c1bf-9519-4dbf-940a-7a15fc2ae563
Stoodley, Paul
08614665-92a9-4466-806e-20c6daeb483f
Hall-Stoodley, Luanne
94ebdc00-b549-4488-b15f-5310fb965f5b
Costerton, J. William
3561239b-c96e-41af-9228-4fc120466c4b
December 2003
Fux, Christoph A.
14e6c1bf-9519-4dbf-940a-7a15fc2ae563
Stoodley, Paul
08614665-92a9-4466-806e-20c6daeb483f
Hall-Stoodley, Luanne
94ebdc00-b549-4488-b15f-5310fb965f5b
Costerton, J. William
3561239b-c96e-41af-9228-4fc120466c4b
Fux, Christoph A., Stoodley, Paul, Hall-Stoodley, Luanne and Costerton, J. William
(2003)
Bacterial biofilms: a diagnostic and therapeutic challenge.
Expert Review of Anti-Infective Therapy, 1 (4), .
(doi:10.1586/14787210.1.4.667).
Abstract
Bacteria have traditionally been regarded as individual organisms growing in homogeneous planktonic populations. However, bacteria in natural environments usually form communities of surface-adherent organisms embedded in an extracellular matrix, called biofilms. Current antimicrobial strategies often fail to control bacteria in the biofilm mode of growth. Treatment failure is particularly frequent in association with intracorporeal or transcutaneous medical devices and compromised host immunity. The rising prevalence of these risk factors over the last decades has paralleled the increase in biofilm infections. This review discusses the shortcomings of current therapies against biofilms both in theory and with clinical examples. Biofilm characteristics are described with a focus on new diagnostic and therapeutic targets.
This record has no associated files available for download.
More information
Published date: December 2003
Organisations:
Engineering Mats & Surface Engineerg Gp
Identifiers
Local EPrints ID: 157115
URI: http://eprints.soton.ac.uk/id/eprint/157115
ISSN: 1478-7210
PURE UUID: 4306d5d0-11b5-4a9c-ae23-df88a2ff8208
Catalogue record
Date deposited: 09 Jun 2010 10:58
Last modified: 14 Mar 2024 02:55
Export record
Altmetrics
Contributors
Author:
Christoph A. Fux
Author:
Luanne Hall-Stoodley
Author:
J. William Costerton
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics